IL160515A0 - Transdermal therapeutic system (tts) with fentanyl as active ingredient - Google Patents

Transdermal therapeutic system (tts) with fentanyl as active ingredient

Info

Publication number
IL160515A0
IL160515A0 IL16051502A IL16051502A IL160515A0 IL 160515 A0 IL160515 A0 IL 160515A0 IL 16051502 A IL16051502 A IL 16051502A IL 16051502 A IL16051502 A IL 16051502A IL 160515 A0 IL160515 A0 IL 160515A0
Authority
IL
Israel
Prior art keywords
active ingredient
fentanyl
transdermal therapeutic
tts
therapeutic system
Prior art date
Application number
IL16051502A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL160515A0 publication Critical patent/IL160515A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
IL16051502A 2001-08-24 2002-07-10 Transdermal therapeutic system (tts) with fentanyl as active ingredient IL160515A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141651A DE10141651B4 (de) 2001-08-24 2001-08-24 Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
PCT/EP2002/007663 WO2003018071A1 (de) 2001-08-24 2002-07-10 Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl

Publications (1)

Publication Number Publication Date
IL160515A0 true IL160515A0 (en) 2004-07-25

Family

ID=7696569

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16051502A IL160515A0 (en) 2001-08-24 2002-07-10 Transdermal therapeutic system (tts) with fentanyl as active ingredient
IL160515A IL160515A (en) 2001-08-24 2004-02-23 Intracranial transfer system of fentanyl as the active substance

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160515A IL160515A (en) 2001-08-24 2004-02-23 Intracranial transfer system of fentanyl as the active substance

Country Status (24)

Country Link
US (2) US7390500B2 (xx)
EP (1) EP1418951B1 (xx)
JP (1) JP4628673B2 (xx)
KR (1) KR100895188B1 (xx)
CN (1) CN100438859C (xx)
AT (1) ATE455541T1 (xx)
AU (1) AU2002321199B2 (xx)
BR (1) BRPI0212028B8 (xx)
CA (1) CA2457245C (xx)
CY (1) CY1109954T1 (xx)
DE (2) DE10141651B4 (xx)
DK (1) DK1418951T3 (xx)
ES (1) ES2339640T3 (xx)
HK (1) HK1069534A1 (xx)
HU (1) HU229942B1 (xx)
IL (2) IL160515A0 (xx)
MX (1) MXPA04001679A (xx)
NZ (1) NZ530795A (xx)
PL (1) PL204348B1 (xx)
PT (1) PT1418951E (xx)
RU (1) RU2311908C2 (xx)
TW (1) TW570815B (xx)
WO (1) WO2003018071A1 (xx)
ZA (1) ZA200400473B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
RU2348397C2 (ru) * 2003-02-07 2009-03-10 Лтс Ломанн Терапи-Системе Аг Трансдермальная терапевтическая система, пригодная для использования тепла с целью ускорения проникновения биологически активных веществ, и ее применение
PL219512B1 (pl) * 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego
US20110086086A1 (en) * 2005-07-26 2011-04-14 Pfizer Inc Transdermal system for varenicline
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum
GB0615429D0 (en) * 2006-08-03 2006-09-13 Chowdhury Dewan F H Transdermal drug delivery with temporal control
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
DE102008016804B4 (de) * 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
IN2012DN00845A (xx) * 2009-07-21 2015-06-26 Mylan Inc
US9822088B2 (en) 2011-03-30 2017-11-21 The United States Of America As Represented By The Administrator Of Nasa Anisotropic copoly(imide oxetane) coatings and articles of manufacture, copoly(imide oxetane)s containing pendant fluorocarbon moieties, oligomers and processes therefor
DE102011080390B3 (de) * 2011-08-03 2012-07-12 Acino Ag Applikationshilfe
TW201338813A (zh) 2011-12-12 2013-10-01 Lohmann Therapie Syst Lts 經皮遞送系統
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
JP6559121B2 (ja) 2013-06-04 2019-08-14 エルテーエス ローマン テラピー−ジステーメ アーゲー 経皮送達システム
CA2916183C (en) 2013-07-03 2022-03-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with electronic component
EP4238580A3 (en) 2014-05-20 2023-10-25 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an interface mediator
CA2948219C (en) 2014-05-20 2023-04-04 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
CA2948220C (en) 2014-05-20 2023-06-20 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system containing rotigotine
US9962340B2 (en) 2015-06-09 2018-05-08 Life Tech Global, Llc Device and method for the transdermal delivery of cannabidiol
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
DE102017107468B4 (de) 2017-04-06 2019-02-21 Lts Lohmann Therapie-Systeme Ag Verfahren zur herstellung eines, insbesondere oralen, wirkstofflaminats und wirkstofflaminat, insbesondere orales wirkstofflaminat
JP7175913B2 (ja) 2017-04-18 2022-11-21 ブレイクスルー・テクノロジーズ・エルエルシー 硫黄生成
EP3678646B1 (en) * 2017-09-04 2021-09-29 LTS Lohmann Therapie-Systeme AG Transdermal delivery system including an emulsifier
JP6912122B2 (ja) * 2019-02-28 2021-07-28 日本臓器製薬株式会社 経皮投与製剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4822802A (en) * 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
FR2623718B1 (fr) * 1987-11-27 1994-04-15 Fabre Medicament Pierre Dispositif therapeutique transdermique et son procede de preparation
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3905051A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
JP3202777B2 (ja) * 1992-01-24 2001-08-27 リンテック株式会社 経皮吸収促進剤及びテープ製剤
JP3489831B2 (ja) * 1993-04-20 2004-01-26 ヘクサル・アクチエンゲゼルシャフト 活性成分パッチ
CN1094972A (zh) * 1993-05-21 1994-11-16 深圳广信生物工程公司 控释透皮治疗***及其制备与应用
JP3240496B2 (ja) * 1993-09-30 2001-12-17 タキロン株式会社 経皮吸収製剤
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung
KR19980025307A (ko) * 1998-04-11 1998-07-06 조태임 진통효과를 갖는 약물의 경피흡수제제
US6312715B1 (en) * 1998-05-01 2001-11-06 3M Innovative Properties Company Adhesive microsphere drug delivery composition
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
ES2194736T3 (es) * 1999-07-02 2003-12-01 Lohmann Therapie Syst Lts Sistema de microdepositos sobre la base de polisiloxanos y disolvente ambifilos.
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices

Also Published As

Publication number Publication date
US7390500B2 (en) 2008-06-24
RU2004108849A (ru) 2005-05-10
PL204348B1 (pl) 2010-01-29
US20040234583A1 (en) 2004-11-25
CN1545407A (zh) 2004-11-10
US20080274167A1 (en) 2008-11-06
HUP0401512A3 (en) 2012-08-28
PL366857A1 (en) 2005-02-07
BRPI0212028B8 (pt) 2021-05-25
EP1418951A1 (de) 2004-05-19
CA2457245A1 (en) 2003-03-06
DK1418951T3 (da) 2010-05-10
ZA200400473B (en) 2004-10-14
HK1069534A1 (xx) 2005-05-27
CY1109954T1 (el) 2012-05-23
IL160515A (en) 2009-09-22
KR100895188B1 (ko) 2009-04-24
CA2457245C (en) 2010-09-07
EP1418951B1 (de) 2010-01-20
BR0212028A (pt) 2004-08-03
HUP0401512A2 (hu) 2004-12-28
PT1418951E (pt) 2010-04-07
MXPA04001679A (es) 2004-05-31
DE10141651A1 (de) 2003-03-13
TW570815B (en) 2004-01-11
NZ530795A (en) 2005-08-26
HU229942B1 (en) 2015-01-28
RU2311908C2 (ru) 2007-12-10
DE50214184D1 (de) 2010-03-11
CN100438859C (zh) 2008-12-03
WO2003018071A1 (de) 2003-03-06
AU2002321199B2 (en) 2007-08-16
KR20040029021A (ko) 2004-04-03
JP4628673B2 (ja) 2011-02-09
ATE455541T1 (de) 2010-02-15
BRPI0212028B1 (pt) 2020-11-24
ES2339640T3 (es) 2010-05-24
JP2005501865A (ja) 2005-01-20
DE10141651B4 (de) 2007-02-15

Similar Documents

Publication Publication Date Title
IL160515A0 (en) Transdermal therapeutic system (tts) with fentanyl as active ingredient
AU2002321199A1 (en) Transdermal therapeutic system (TTS) with fentanyl as active ingredient
DE60129849D1 (de) Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe
ATE342097T1 (de) Elektroaktive pore
ES2176234T3 (es) Sistema terapeutico transdermal con galantamina como componente activo.
ES2164780T3 (es) Dispositivo transdermico mejorado con desestratificacion reducida.
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
WO2001068060A3 (de) Stabilisierte übersättigte transdermale therapeutische matrixsysteme
MXPA04001676A (es) Sistema terapeutico transdermico con fentanilo o sustancias relacionadas.
NZ541807A (en) UV stable transdermal therapeutic plaster
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
DE50010108D1 (de) Desoxypeganin-tts
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
DK1143938T3 (da) Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DE50208253D1 (de) Transdermales therapeutisches system zur verabreichung des partiellen dopamin-d2-agonisten aripiprazol
WO2001003678A3 (de) Transdermales therapeutisches system zur anwendung von tolterodin
WO2003026555A3 (en) Floating osmotic device for controlled release drug delivery